Medicare Enrolled
Dr. Joseph Kassa, D.O.
Neurology · Roseville, MI
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kassa from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kassa?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kassa
Dr. Joseph Kassa is a neurology specialist in Roseville, MI, with 12 years of NPI registration. Based on federal Medicare data, Dr. Kassa performed 6,788 Medicare services across 1,069 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kassa received a total of $13,406 from 72 pharmaceutical and/or device companies across 770 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kassa is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 6% volume in MI
$13,406 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,788
Medicare services
Top 6% in MI for neurology
1,069
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~566 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,325 | $5 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $91 | $207 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
179 | $65 | $119 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
135 | $105 | $211 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
131 | $84 | $228 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
100 | $60 | $142 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
91 | $4 | $17 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
64 | $165 | $503 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
57 | $46 | $185 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $124 | $268 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
50 | $348 | $1,044 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
41 | $12 | $43 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
39 | $16 | $72 |
| New patient office visit, complex (60-74 min) | 34 | $159 | $343 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $128 | $263 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
29 | $92 | $152 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
26 | $81 | $407 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
26 | $133 | $442 |
| Awake and drowsy EEG A test that records electrical activity in the brain while the patient is awake and drowsy. |
25 | $291 | $891 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 21 | $42 | $360 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
19 | $1 | $4 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
17 | $125 | $312 |
| Nerve conduction studies, 5-6 tests A series of 5 to 6 tests that measure how well nerves send electrical signals. The procedure evaluates nerve function and helps identify damage or dysfunction. |
14 | $108 | $336 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
82.9% medium
15.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,406
Total received (2018-2024)
Avg $1,915/year across 7 years
Top 20% in MI for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
770
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,118 (97.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$289 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,443
2023
$1,940
2022
$3,100
2021
$1,817
2020
$1,432
2019
$2,478
2018
$1,196
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$315
Novartis Pharmaceuticals Corporation
$200
UCB, Inc.
$161
Neurocrine Biosciences, Inc.
$90
PFIZER INC.
$77
Lilly USA, LLC
$77
Biogen, Inc.
$66
Amgen Inc.
$49
Lundbeck LLC
$47
Philips North America LLC
$46
Teva Pharmaceuticals USA, Inc.
$45
Alexion Pharmaceuticals, Inc.
$43
ACADIA Pharmaceuticals Inc
$40
Celgene Corporation
$29
GE HEALTHCARE
$28
Ipsen Biopharmaceuticals, Inc
$22
CATALYST PHARMACEUTICALS, INC.
$22
ARGENX US, INC.
$21
Eisai Inc.
$21
Azurity Pharmaceuticals, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
TG Therapeutics, Inc.
$14
Top 3 companies account for 46.9% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,457
UCB, Inc.
$1,134
ABBVIE INC.
$1,119
Teva Pharmaceuticals USA, Inc.
$923
Biogen, Inc.
$840
EMD Serono, Inc.
$586
GENZYME CORPORATION
$560
Amgen Inc.
$490
Genentech USA, Inc.
$419
Lilly USA, LLC
$382
Celgene Corporation
$357
Eisai Inc.
$346
Adamas Pharmaceuticals, Inc.
$303
Sunovion Pharmaceuticals Inc.
$293
PFIZER INC.
$230
Neurocrine Biosciences, Inc.
$222
ACADIA Pharmaceuticals Inc
$207
Allergan, Inc.
$202
Alexion Pharmaceuticals, Inc.
$188
Biohaven Pharmaceutical Holding Company Ltd.
$187
Lundbeck LLC
$168
JAZZ PHARMACEUTICALS INC.
$156
Neurelis, Inc.
$151
Janssen Pharmaceuticals, Inc
$150
Acorda Therapeutics, Inc
$147
Amneal Pharmaceuticals LLC
$141
CSL Behring
$126
Vertiflex, Inc.
$124
Avanir Pharmaceuticals, Inc.
$120
Allergan Inc.
$109
AbbVie, Inc.
$92
Biohaven Pharmaceuticals, Inc.
$75
MDD US Operations, LLC
$72
Otsuka America Pharmaceutical, Inc.
$70
CATALYST PHARMACEUTICALS, INC.
$68
Ipsen Biopharmaceuticals, Inc
$67
US WorldMeds, LLC
$63
Vertical Pharmaceuticals, LLC
$63
Validus Pharmaceuticals LLC
$62
AbbVie Inc.
$61
Bayer HealthCare Pharmaceuticals Inc.
$58
GE HEALTHCARE
$55
ARGENX US, INC.
$53
Biosense Webster, Inc.
$53
TG THERAPEUTICS, INC.
$47
Philips North America LLC
$46
Catalyst Pharmaceuticals, Inc.
$41
Bausch Health US, LLC
$41
Harmony Biosciences LLC
$40
EISAI INC.
$38
Kyowa Kirin, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$31
Mallinckrodt Enterprises LLC
$29
SANOFI-AVENTIS U.S. LLC
$25
IMPEL PHARMACEUTICALS INC.
$23
AQUESTIVE THERAPEUTICS, INC.
$22
SK Life Science, Inc.
$20
Corium, LLC
$20
Horizon Therapeutics plc
$18
MITSUBISHI TANABE PHARMA AMERICA, INC.
$18
Greenwich Biosciences, Inc.
$17
Mitsubishi Tanabe Pharma America, Inc.
$17
Azurity Pharmaceuticals, Inc.
$16
Upsher-Smith Laboratories LLC
$15
TG Therapeutics, Inc.
$14
Grifols USA, LLC
$14
ARBOR PHARMACEUTICALS, INC.
$14
OWP Pharmaceuticals, Inc.
$14
Saol Therapeutics Inc.
$13
Impax Laboratories, Inc.
$13
Zyla Life Sciences, Inc.
$13
Jazz Pharmaceuticals Inc.
$11
Top 3 companies account for 27.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Adlarity · Aimovig · Austedo XR · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Betaseron · Briviact · CARTO 3 · COMIRNATY · COPAXONE · Carto 3 System · DUOPA · DYSPORT · Dayvigo · Duopa · Dysport · EMGALITY · EPIDIOLEX · Enspryng · Epidiolex · Equetro · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · LEMTRADA · LYRICA · Lamotrigine Starter Kit · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · OCREVUS · OSMOLEX ER · PLEGRIDY · Ponvory · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QULIPTA · RADICAVA · RELEXXII · REXULTI · RYTARY · Radicava · Rebif · SOLIRIS · SPINRAZA · SPRIX · SYMPAZAN · Soliris · Superion ISS · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · Vimpat · Wakix · XARELTO · XYWAV · Xadago · Xyrem · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
258
Per 100K population
29.4
County median income
$76,399
Nearest hospital
Henry Ford Health Warren Hospital
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kassa is a mixed practice specialist, with above-average Medicare volume (top 6% in MI), with low-engagement industry engagement in the top 20% of MI peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kassa experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Kassa performed 5,325 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kassa receive payments from pharmaceutical companies?
Yes. Dr. Kassa received a total of $13,406 from 72 companies across 770 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kassa's costs compare to other neurologists in Roseville?
Dr. Kassa's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kassa) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Roseville
Browse neurologists in Roseville ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in MI
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in MI
Which MI neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology